CBPE Capital related stories
All articles and analysis
Should you use a placement agent on your next fund?The pros and cons of in-house versus outsourced capital raising was debated at PEI’s Investor Relations forum this week.
Side Letter: HIG, CBPE and Endless toast pandemic fundraising success, Chinese GPs face headwindsA string of pandemic-busting mid-market fundraises to note today, plus some less rosy fundraising anecdotes for GPs investing in China. Here's today's brief, for our valued subscribers only.
Future 40: Who’s showing private equity leadership?Who are the young guns showing innovation in the industry? Who has the X factor that marks them as a future leader? Our Future 40 list of the 40 individuals aged under 40 set to shape private equity over the next decade.
Lockheed Martin Investment plans to cut external managersThe US corporate pension will reduce its 80 GPs over time but plans to increase its overall exposure to private equity.
- Chart of the week: Domestic managers dominate in the UK
Just two foreign fund managers make the top 10 ranking of UK-focused firms.
- CBPE closes Fund IX on £459m hard-cap
The UK-focused fund, which had excess demand before the Brexit vote, includes a GP commitment of 2%.
- Oakley holds first close on Fund III – Exclusive
The firm has amassed more than €500m for its latest vehicle, which has a hard-cap of €750m.
- CBPE hits £400m mark on Fund IX – Exclusive
The UK mid-market firm is defying Brexit uncertainty as it hurtles toward its £425m target.
- CBPE IX races toward target – Exclusive
The fund, which officially launched last May, is expected to reach its £425m target by the summer.
- CBPE nets 22x on IDIS
AIM-listed pharma company Clinigen Group will pay £225m for the unlicensed medicines importer and supplier